Product Images Afinitor Disperz

View Photos of Packaging, Labels & Appearance

everolimus structural formula - afinitor 01
Figure 2: Kaplan-Meier Investigator-Determined Progression-free Survival Curves - afinitor 02
Figure 4: Kaplan-Meier Progression-free Survival Curves - afinitor 03
PRINCIPAL DISPLAY PANEL NDC 0078-0594-51 Rx only 28 Tablets Carton contains 4 individual blister cards of 7 tablets. AFINITOR® (everolimus) tablets Each tablet contains 2.5 mg everolimus NOVARTIS - afinitor 04
PRINCIPAL DISPLAY PANEL NDC 0078-0566-51 Rx only 28 Tablets Carton contains 4 individual blister cards of 7 tablets. AFINITOR® (everolimus) tablets Each tablet contains 5 mg everolimus NOVARTIS - afinitor 05
PRINCIPAL DISPLAY PANEL NDC 0078-0567-51 Rx only 28 Tablets Carton contains 4 individual blister cards of 7 tablets. AFINITOR® (everolimus) tablets Each tablet contains 10 mg everolimus NOVARTIS - afinitor 06
PRINCIPAL DISPLAY PANEL NDC 0078-0620-51 Rx only 28 Tablets Carton contains 4 individual blister cards of 7 tablets. AFINITOR® (everolimus) tablets Each tablet contains 7.5 mg everolimus NOVARTIS - afinitor 07
Figure 1: Kaplan-Meier Progression-free Survival Curves (Investigator Radiological Review) - afinitor 08
PRINCIPAL DISPLAY PANEL NDC 0078-0626-51 Rx only 28 Tablets for Oral Suspension Carton contains 4 individual blister cards of 7 tablets. AFINITOR DISPERZ® (everolimus tablets for oral suspension) 2 mg TABLETS MUST BE DISPERSED IN WATER. TABLETS MUST NOT BE SWALLOWED WHOLE, CHEWED OR CRUSHED. Each tablet contains 2 mg everolimus NOVARTIS - afinitor 09
Figure A - afinitor 0A
Figure B - afinitor 0B
Figure C - afinitor 0C
Figure D - afinitor 0D
Figure E - afinitor 0E
Figure F - afinitor 0F
Figure G - afinitor 0G
Figure H - afinitor 0H
Figure I - afinitor 0I
Figure J - afinitor 0J
Figure K - afinitor 0K
Figure L - afinitor 0L
Figure M - afinitor 0M
Figure N - afinitor 0N
Figure O - afinitor 0O
Figure P - afinitor 0P
Figure Q - afinitor 0Q
Figure R - afinitor 0R
Figure S - afinitor 0S
Figure T - afinitor 0T
Figure U - afinitor 0U
Figure V - afinitor 0V
Figure W - afinitor 0W
Figure X - afinitor 0X
Figure Y - afinitor 0Y
Figure Z - afinitor 0Z
PRINCIPAL DISPLAY PANEL NDC 0078-0627-51 Rx only 28 Tablets for Oral Suspension Carton contains 4 individual blister cards of 7 tablets. AFINITOR DISPERZ® (everolimus tablets for oral suspension) 3 mg TABLETS MUST BE DISPERSED IN WATER. TABLETS MUST NOT BE SWALLOWED WHOLE, CHEWED OR CRUSHED. Each tablet contains 3 mg everolimus NOVARTIS - afinitor 10
PRINCIPAL DISPLAY PANEL NDC 0078-0628-51 Rx only 28 Tablets for Oral Suspension Carton contains 4 individual blister cards of 7 tablets. AFINITOR DISPERZ® (everolimus tablets for oral suspension) 5 mg TABLETS MUST BE DISPERSED IN WATER. TABLETS MUST NOT BE SWALLOWED WHOLE, CHEWED OR CRUSHED. Each tablet contains 5 mg everolimus NOVARTIS - afinitor 11
Figure 3: Kaplan-Meier Progression-free Survival Curves - afinitor 12
Figure AA - afinitor AA
Figure BB - afinitor BB
Figure CC - afinitor CC
Figure DD - afinitor DD
Figure EE - afinitor EE

Product Label Images

The following 43 images provide visual information about the product associated with Afinitor Disperz NDC 0078-0626 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

everolimus structural formula - afinitor 01

Figure 2: Kaplan-Meier Investigator-Determined Progression-free Survival Curves - afinitor 02

This is a statistical report on the probability of a hazard ratio with corresponding confidence intervals, p-value, and Kaplan-Meier medians based on a clinical trial comparing the effectiveness of Afinitor and Placebo. The data shows that Afinitor had a significantly longer duration of survival compared to Placebo. The data also includes a graph of the censoring times for both treatment groups over time.*

Figure 4: Kaplan-Meier Progression-free Survival Curves - afinitor 03

This text provides information on the results of a study or experiment. It includes percentages and hazard ratio with confidence intervals. The logrank p-value is also given. There are two treatments compared: Afinitor and Placebo. The Kaplan-Meier medians are shown for both treatments in terms of months. Additionally, censoring times are provided for both treatments. The time (in months) is listed at the end.*

PRINCIPAL DISPLAY PANEL NDC 0078-0594-51 Rx only 28 Tablets Carton contains 4 individual blister cards of 7 tablets. AFINITOR® (everolimus) tablets Each tablet contains 2.5 mg everolimus NOVARTIS - afinitor 04

This is a description of a box of 28 tablets of Afinitor (everolimus) made by Novartis. The box is labeled with the drug's name and information including contact information for more information. The tablets are only available by prescription. The also included some irregular characters, so the description is not exact, but it reflects what's clear from the text.*

PRINCIPAL DISPLAY PANEL NDC 0078-0566-51 Rx only 28 Tablets Carton contains 4 individual blister cards of 7 tablets. AFINITOR® (everolimus) tablets Each tablet contains 5 mg everolimus NOVARTIS - afinitor 05

This appears to be a description of several tablets containing everolimus, marketed under the brand names AFINITOR and BARCINATOR, in 28-tablet blister cards. The NDC code for the AFINITOR tablets is 0078056651, and their manufacturer is Novartis. The text also provides a phone number and website for obtaining more information about the tablets.*

PRINCIPAL DISPLAY PANEL NDC 0078-0567-51 Rx only 28 Tablets Carton contains 4 individual blister cards of 7 tablets. AFINITOR® (everolimus) tablets Each tablet contains 10 mg everolimus NOVARTIS - afinitor 06

This text appears to be from a medication package of AFINITOR tablets, which contain 10mg of everolimus. The package contains 28 tablets and is only available with a prescription. The manufacturer of the medication is Novartis. More information about the medication is available by visiting www.AFINTOR.com or contacting a toll-free number.*

PRINCIPAL DISPLAY PANEL NDC 0078-0620-51 Rx only 28 Tablets Carton contains 4 individual blister cards of 7 tablets. AFINITOR® (everolimus) tablets Each tablet contains 7.5 mg everolimus NOVARTIS - afinitor 07

AFINITOR is a medication contained in a box of 28 tablets with a NDC number of 0078062051. Each tablet contains everolimus and is Rx-only. For more information about AFINITOR, visit their website or call their hotline.*

Figure 1: Kaplan-Meier Progression-free Survival Curves (Investigator Radiological Review) - afinitor 08

The text provides information on the progression-free survival probability of two different treatments, Everolimus 10mg - exemestane, and Placebo-exemestane. The Kaplan-Meier medians indicate that Everolimus has a median progression-free survival probability of 7.8 months while the Placebo-exemestane treatment has a median progression-free survival probability of 32 months. The log-rank p-value is <0001 and there were four censoring times. The text also includes a graph representing the progression-free survival probability over time (in months) for both treatments.*

PRINCIPAL DISPLAY PANEL NDC 0078-0626-51 Rx only 28 Tablets for Oral Suspension Carton contains 4 individual blister cards of 7 tablets. AFINITOR DISPERZ® (everolimus tablets for oral suspension) 2 mg TABLETS MUST BE DISPERSED IN WATER. TABLETS MUST NOT BE SWALLOWED WHOLE, CHEWED OR CRUSHED. Each tablet contains 2 mg everolimus NOVARTIS - afinitor 09

This appears to be a medication information leaflet for AFINITOR DISPERZ - a brand of everolimus tablets for oral suspension used for treating certain types of cancer. The text mentions the dosage (2mg), and instructions cautioning against swallowing the tablets whole, chewing, or crushing them.*

Figure A - afinitor 0A

Figure B - afinitor 0B

Figure C - afinitor 0C

Figure D - afinitor 0D

Figure E - afinitor 0E

Figure F - afinitor 0F

Figure G - afinitor 0G

Figure H - afinitor 0H

Figure I - afinitor 0I

Figure J - afinitor 0J

Figure K - afinitor 0K

Figure L - afinitor 0L

Figure M - afinitor 0M

Figure N - afinitor 0N

Figure O - afinitor 0O

Figure P - afinitor 0P

Figure Q - afinitor 0Q

Figure R - afinitor 0R

Figure S - afinitor 0S

Figure T - afinitor 0T

Figure U - afinitor 0U

Figure V - afinitor 0V

Figure W - afinitor 0W

Figure X - afinitor 0X

Figure Y - afinitor 0Y

Figure Z - afinitor 0Z

PRINCIPAL DISPLAY PANEL NDC 0078-0627-51 Rx only 28 Tablets for Oral Suspension Carton contains 4 individual blister cards of 7 tablets. AFINITOR DISPERZ® (everolimus tablets for oral suspension) 3 mg TABLETS MUST BE DISPERSED IN WATER. TABLETS MUST NOT BE SWALLOWED WHOLE, CHEWED OR CRUSHED. Each tablet contains 3 mg everolimus NOVARTIS - afinitor 10

AFINITOR DISPERZ is a medication that comes in tablet form containing everolimus and is available in a strength of 3mg. The tablets must not be swallowed whole, chewed or crushed. They must be dispersed in water before consumption. The provided text seems to be a warning or instruction for proper medication intake.*

PRINCIPAL DISPLAY PANEL NDC 0078-0628-51 Rx only 28 Tablets for Oral Suspension Carton contains 4 individual blister cards of 7 tablets. AFINITOR DISPERZ® (everolimus tablets for oral suspension) 5 mg TABLETS MUST BE DISPERSED IN WATER. TABLETS MUST NOT BE SWALLOWED WHOLE, CHEWED OR CRUSHED. Each tablet contains 5 mg everolimus NOVARTIS - afinitor 11

This is a description of medication called AFINITOR DISPERZ (everolimus tablets for oral suspension) available in 5mg strength. The tablets should not be swallowed whole or chewed. They must be dispersed in water before taking. There are additional details about the product that are not available in the provided text.*

Figure 3: Kaplan-Meier Progression-free Survival Curves - afinitor 12

This appears to be a graph displaying the probability of an event over time (in months) for two groups of patients - one group on Everolimus + BSC and the other on Placebo + BSC. The number of patients at risk for each group is also shown over time.*

Figure AA - afinitor AA

Figure BB - afinitor BB

Figure CC - afinitor CC

Figure DD - afinitor DD

Figure EE - afinitor EE

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents